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Role of CD81 cells in the progression of murine adriamycin Studies in several models of inflammatory renal dis-
nephropathy. ease have demonstrated that sensitized T cells were an
Background. Many studies have shown that interstitial in- important component of the renal lesion [1–4] and couldflammation in human and experimental renal disease is char-
passively transfer disease to tolerant hosts [5, 6]. Specifi-acterized by T-cell infiltration, but published data on the
cally, CD81 T cells have been shown to play an importantinvolvement of inflammatory cell subsets in progressive tubulo-
interstitial lesions are often conflicting. A previous study sug- effector role in various types of immune-mediated renal
gested a role for cytotoxic T lymphocytes in the damaging disease [5, 7–9]. Penny, Boyd, and Hall demonstrated
effect of CD41 T-cell depletion in murine adriamycin (ADR) that renal injury in Heymann nephritis is mediated by
nephropathy, a model of focal segmental glomerulosclerosis
CD81 cytotoxic T-lymphocytes (CTL) [8]. Furthermore,(FSGS), and tubulointerstitial inflammation. The aim of this
CD81 T cells were regarded as the ultimate effector Tstudy was to investigate the role of CD81 cells in this model.
Methods. Male BALB/c mice were treated with five intra- cells of glomerular injury in nephrotoxic serum nephritis
peritoneal injections of anti-CD8 monoclonal antibody (mAb), [9] and interstitial damage in antitubular basement mem-
beginning from five days after ADR treatment, when overt brane (TBM) disease [7]. However, to the best of our
proteinuria was established. Seven mice in each of groups A knowledge, no study has examined the role of CD81 cells(ADR 1 mAb), B (ADR only), and C (saline treated, age
in the progression of adriamycin (ADR)-nephropathy.matched) were sacrificed at week 6. Changes in renal function
Previous studies in our laboratory have suggested aand histopathological features were assessed. Tubulointerstitial
inflammation and glomerular inflammation were examined im- pathogenetic role for CD81 cells in ADR nephropathy in
munohistochemically. BALB/c mice, a robust model of human focal segmental
Results. mAb treatment reduced CD81 cell levels to ,2% glomerulosclerosis (FSGS), and one usually regarded asof normal in spleen. Proteinuria in group A was no different
nonimmunological [10]. The prominence of CD41 andfrom that in group B at week 6, but was markedly higher than
CD81 cells in the tubulointerstitium in this model sug-in group C. Creatinine clearance was significantly ameliorated
by anti-CD8 treatment (71.8 6 4.9 mL/min vs. 29.2 6 2.8 in gested that these cells might play an important part in
group B and 81.9 6 3.7 in group C). Morphometric analysis the pathogenesis of the interstitial lesion of ADR ne-
showed less FSGS in group A compared with group B (6.5 6 phropathy. In vivo CD41 cell depletion aggravated the
1.9 vs. 13.0 6 2.8, P , 0.001), as well as less tubular atrophy
histologic and functional damage and was associated(indicated by increased ratio of tubule cell height to tubular
with an increase in interstitial CD81 cells and macro-diameter, 0.25 6 0.24 in group A vs. 0.04 6 0.02 in group B,
phages (unpublished data). The results raised the possi-P , 0.05). CD8 depletion also reduced interstitial expansion
(6.3 6 2.2% vs. 16.4 6 3.1 in group B, P , 0.001) and fibrosis bility that interstitial CD81 cells might play a key role
(P , 0.01). Macrophage infiltration in tubulointerstitium was in the progression of chronic renal disease in mice with
less in group A than in group B (P 5 0.052). The number of ADR-induced nephrosis.interstitial CD41 cells appeared to increase after anti-CD8
In the current study, to test the hypothesis that intersti-treatment, but was not statistically different between groups
tial CD81 cell inflammation modulates the expressionA and B.
Conclusion. Anti-CD8 treatment protects against renal func- of chronic proteinuric renal disease, we determined the
tional and structural injury in this murine model of chronic pro- effect of in vivo depletion of CD81 cells on the functional
teinuric renal disease. and pathological progression of established murine
ADR nephropathy.
Key words: focal segmental glomerulosclerosis, interstitial damage,
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tained free of specific pathogens and under constant tem- FACS analysis
perature (228C) and humidity, on a 12-hour light/dark Antibodies used for flow cytometry are listed in Table
cycle in the Animal House of Westmead Hospital. They 1. Spleen cells from individual mice were obtained at
were given acidified water and commercial mouse chow day 42. All of the following steps were performed on ice
(protein 18.9%; Glen Forrest Stockfeeders, Glen Forrest, or at 48C to prevent capping off of membrane molecules,
WA, Australia) ad libitum. Seven- to eight-week-old (20 unless stated otherwise. Spleen was crushed using a sy-
to 25 g body wt) male mice were used in all groups at the ringe plunger, and splenocytes were separated in RPMI
commencement of the experiments. 1640 medium (GIBCO BRL Life Technologies Inc.,
Mice were divided into three groups. Group C was the Grand Island, New York, USA) with 10% (vol/vol) fetal
negative control group in which mice were treated with calf serum (FCS; Trace Biosciences Pty Ltd., Castle Hill,
NSW, Australia). Suspensions were then separated byisotonic saline. Group B was the positive control treated
centrifugation at 200 3 g for five minutes in a Laboratorywith ADR (doxorubicin hydrochloride; Pharmacia &
4K15 Centrifuge (Quantum Scientific Pty Ltd., Milton,Upjohn Pty Ltd., Perth, Australia) by a single injection
QLD, Australia). After lysing red blood cells using lysingof 10 to 11 mg/kg body weight via the tail vein of each
buffer [150 mmol/L ammonium chloride, 10 mmol/L po-nonanesthetized mouse. Group A was the experimental
tassium carbonate, 0.1 mmol/L Na4-ethylenediaminetet-group in which mice were treated with ADR plus anti-
raacetic acid (EDTA), pH 7.5], the cells was resuspendedCD8 monoclonal antibody (mAb). All control and
in 2 mL of RPMI 1640 medium with 10% fetal calf serumtreated mice were housed individually in one plastic cage
(FCS) and 1% NaN3. After staining with 1% trypan blueafter treatment. Samples from seven mice in each group
dye (Sigma Chemical Company), the number of viablewere obtained.
cells was determined using a counting chamber. Cell sus-
pensions containing 3 3 105 splenocytes were placed inMonoclonal antibody administration
Falcon FACS tubes (Becton Dickinson, Lincoln Park, NJ,Mice in group A were injected intraperitoneally with
USA), incubated with 20% normal goat serum (Sigma)500 mg rat anti-mouse CD8 mAb (hybridoma 53-6.7) per
to block the cell surface Fc receptors, and then incubatedmouse each time [11–13]. Mice were inoculated com-
with 2 mL of the relevant antibodies for 30 minutes inmencing on day 5 after administration of ADR, when
the dark. After washing twice, cells were fixed with 2%overt proteinuria had already appeared. Mice were then
(wt/vol) paraformaldehyde and stored in the dark at 48Creinoculated intraperitoneally with the same volume of
until analysis. Meanwhile, isotype control antibody wasmAb on days 6, 7, 21, and 35, to maintain the depleted
used to obtain background fluorescence values.state until sacrifice on day 42. On the same days, equal
The samples were analyzed using Becton Dickinsonvolumes of rat immunoglobulin (Sigma Chemical Com-
Immunocytometry Systems Version 1.1 (Becton Dickin-pany, St. Louis, MO, USA) were given to negative and
son, San Jose, CA, USA). Data were collected on 10,000
positive control mice. The extent of CD81 cell depletion
cells and are shown as contour diagrams.
was assessed by fluorescence-activated cell sorter (FACS).
Depletion was invariably .98% during entire experi- Histology
mental period. Paraffin embedded kidney was sectioned at 4 micron (m)
onto poly-l-lysine (Sigma)-coated slides. The slides wereTissue preparation
stained with periodic acid-Schiff (PAS), hematoxylin and
All mice were sacrificed at day 42 after the day of ADR eosin (HE), and Masson’s trichrome. The PAS stain was
treatment (day 0). Prior to sacrifice, animals were anes- used to evaluate glomerulosclerosis. The HE stain was
thetized using a mixture of ketamine and xylazine (keta- used to enumerate nuclei in glomeruli and cellular infil-
mine, 100 mg/kg body weight; xylazine, 8 mg/kg body tration in interstitial areas. Masson’s trichrome was used
weight) intraperitoneally. After cardiac puncture for to evaluate fibrosis in tubulointerstitium.
blood sample collection, animals were completely exsan- Morphometric studies were performed quantitatively
guinated via the abdominal aorta before kidney and using Optimas image analysis system (Optimas Corpora-
spleen harvesting to minimize the number of circulating tion, Seattle, WA, USA). Parameters evaluated were
inflammatory cells remaining in the tissue. Kidney weight glomerular surface area, glomerular capillary area, mes-
and body weight were measured immediately. All kidney angial matrix area, number of nuclei per glomerulus,
and spleen specimens were processed without delay. interstitial volume, tubular diameter, and tubule cell
Each kidney was divided into two pieces. One piece height. Glomerulosclerosis was defined as the percentage
was fixed in 10% neutral-buffered formalin solution and increase in relative mesangial matrix area (PAS-positive
embedded in paraffin. For immunohistochemical (IHC) area within the glomerulus divided by the glomerular
capillary area, magnification 3400) [14]. The degree ofstaining, the other piece was frozen in a plastic mold.
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Table 1. Antibodies used in FACS and IHC staining
Clone CD-antigen Cell specificities Sources
H129.19 Rat anti-mouse L3T4 CD41 cells Sigma
53-6.7 Rat anti-mouse Ly-2 CD81 cells PharMingen, Inc.
M3/84 Rat anti-mouse Mac-3 Macrophages PharMingen, Inc.
RA3-6B2 Rat anti-mouse CD45R/B220 Pan-B cells PharMingen, Inc.
R35-95 Rat IgG2a, k Isotype standard PharMingen, Inc.
interstitial expansion was quantitated using the relative nous peroxidase activity was blocked by incubating sec-
tions for 15 minutes in 0.3% (vol/vol) H2O2 solutioninterstitial volume on PAS-stained sections. Tubular at-
rophy was defined as the presence of dilated tubules with in phosphate-buffered saline. Blocking of endogenous
avidin binding activity was achieved by incubating thecellular degeneration (low cell height and absence of
brush border) and thickened, wrinkled basement mem- sections with Biotin Blocking System (Dako). The slides
were then washed for five minutes in Tris-buffered salinebrane. To quantitate tubular atrophy, the cross-sectional
tubular diameter and tubule cell height were measured, [TBS; 0.8% Tris-HCl (Sigma) and 0.9% NaCl (Sigma),
pH 7.6] and incubated for 15 minutes in blocking reagentas described previously [15]. Mean values were calcu-
lated from each of 20 glomeruli or tubules or 10 random [TBS 1 10% (vol/vol) normal rabbit serum; Dako]. The
incubation with relevant primary antibodies was carriedcortical regions per section, as described previously [10].
In each biopsy, a semiquantitative score was used to out for one to two hours at room temperature (RT).
Control cryostat sections were incubated at the sameevaluate the degree of interstitial fibrosis in a blinded
fashion on Masson’s trichrome-stained sections. The cor- time with control antibody (normal rat immunoglobu-
lin). After rinsing twice in TBS for five minutes each,tical interstitium was defined as the peritubular space
and included the TBM and peritubular capillaries, as sections were incubated with secondary antibodies for
30 minutes at RT. This was followed by rinsing in TBSdescribed previously [15]. Interstitial fibrosis was defined
as the area occupied by trichrome stain positive intersti- and incubation with ABC complex (Zymed Labora-
tories, Inc., San Francisco, CA, USA) for 30 minutes;tium [16, 17]. A minimum of 10 consecutive fields at a
magnification of 3400 were assessed and scored in each 3,39-diaminobenzidine (DAB) substrate-chromogen so-
lution (Dako) was applied for less than five minutes andsection. The degree of interstitial fibrosis was estimated
by evaluating the percentage of interstitial fibrosis per then washed thoroughly in distilled water. Slides were
counterstained with hematoxylin (Sigma), dehydrated,field and was graded on a scale of 0 to 4 [18, 19]: 0 5
normal; 0.5 5 small focal areas of fibrosis; 1 5 fibrosis and cover slipped. All specimens were stained in dupli-
cate. To avoid false negative staining, a section of spleeninvolving less than 10% of the cortical interstitium; 2 5
involvement of up to 25% of the cortical interstitium; was placed and stained on every slide as a positive con-
trol. Positive immunoreactivity resulted in brown stain-3 5 involvement of up to 50 to 75% of the cortical
interstitium; and 4 5 extensive fibrosis involving more ing of the cell membrane. Normal nuclei and cytoplasm
were stained lightly. For assessment of interstitial infil-than 75% of the cortical interstitium.
tration, the positively stained cells located in the tubulo-
Immunohistochemistry interstitial area only were counted from five random
cortical fields (magnification 3400) in each section, andPrimary antibodies used in immunohistochemistry are
also shown in Table 1. The secondary antibody was a the numbers were averaged for each field. Glomerular
macrophage infiltration was evaluated as the number ofbiotinylated rabbit anti-rat immunoglobulin (Dakot
Corporation, Carpinteria, CA, USA). For immunohisto- macrophages per 10 glomerular cross-sections.
chemistry, a piece of transverse section from each kidney
Renal functionor spleen was placed in prelabeled Tissue-Tekt Speci-
men Mold (10 3 10 3 5 mm; Miles Inc., Elkhart, IN, Spontaneously voided urine of each animal was col-
lected for 12 hours in a metabolic cage on the day beforeUSA), surrounded with OCT Compound (Sakura Fine-
tek Inc., Torrance, CA, USA). The mold with tissue sacrifice, with access to water only. Urinary volume and
protein were measured. Blood samples for serum albu-was carefully immersed into liquid nitrogen for about 20
seconds until the block solidified. Five-m sections were min and creatinine were obtained by cardiac puncture
just prior to exsanguination. Total urinary protein wascut at 2228C in a MICROM HM505E cryostat and im-
mediately placed on double-coated slides. After air dry- quantitated using the Bio-Rad protein assay kit (Bio-
Rad Laboratories, Hercules, CA, USA) based on theing for 24 hours, cryostat sections were fixed in cold
Zamboni’s fixative [20] and acetone. The avidin-biotin Bradford dye-binding procedure [21], according to the
manufacturer’s instructions in a DU-68 Spectrophotom-complex (ABC) technique was used as follows. Endoge-
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eter (Beckman Instruments Inc., Irvine, CA, USA), for
which purified bovine serum albumin (BSA; Sigma) at
concentration ranges of 0.2 to 1.4 mg/mL was used as
a reference standard. Serum albumin and plasma and
urinary creatinine were analyzed by the Institute of Clini-
cal Pathology and Medical Research, Westmead Hospi-
tal, using a BM/Hitachi 747 analyzer (Tokyo, Japan). All
samples were tested in duplicate.
Renal function was assessed by serial measurements
of plasma and urinary creatinine. Creatinine clearance
(CCr) was determined according to the conventional
clearance formula, CCr 5 (UCr 3 V)/PCr, where UCr is the
concentration of creatinine in urine, PCr is the concentra- Fig. 1. CD41 and CD81 cell levels as a percentage of the total spleno-
cyte population at week 6. Symbols are: ( ) normal; (h) adriamycintion of creatinine in plasma, and V is the urine flow rate
(ADR); (j) ADR 1 anti-CD8. Values are expressed as mean 6 SD.in milliliters per minute. *P , 0.05 compared with other two groups.
Statistical analysis
All results are expressed as the group mean 6 SD.
nary protein and serum albumin in group A were noStatistical analysis was performed using SPSS 8.0 (SPSS
different to that in group B at week 6. CCr, both uncor-Inc., Chicago, IL, USA). One-way analysis of variance
rected and when corrected for body weight, was restored(ANOVA) was used for multiple comparisons. A P value
almost to normal by CD81 cell depletion.of less than 0.05 was considered statistically significant.
CD81 cell depletion significantly alleviated the histo-
logic manifestations of ADR nephropathy (Fig. 2). Light
RESULTS microscopic examination revealed that glomeruli and tu-
bules were only mildly damaged at week 6 in group APreliminary experiments in our laboratory using FACS
mice, as compared with group B mice. Glomerular sur-analysis showed that a single injection of 500 mg 53-6.7
face area was no different to control in group A mice,mAb in BALB/c mice resulted in a selective depletion
but was significantly diminished in group B mice, whoseof CD81 cells to less than 2% of total splenocytes within
glomeruli had shrunken because of glomerulosclerosis.48 hours of mAb infusion and that the elimination of
A few vacuoles were seen in some glomeruli of groupCD81 cells could be maintained for more than three
A mice, but proliferation of mesangial matrix was mild.weeks. In a group of age-matched BALB/c mice treated
Morphometric analysis showed much less glomeruloscle-with 53-6.7 mAb using the same dosage and time course
rosis in group A than in group B mice (P , 0.001), asas group A, no functional or histologic abnormalities
well as more nuclei per glomerular cross section. Mostwere observed (data not shown). In the present study,
tubules were intact in group A mice, and tubular atrophy
analysis of splenocytes at completion of the experiment was significantly alleviated by anti-CD8 treatment, in
(6 weeks after ADR administration) showed that all mice comparison with group B mice. Furthermore, treatment
treated with 53-6.7 mAb had a greatly reduced number with anti-CD8 mAb reduced interstitial expansion in
of CD81 cells compared with mice treated with rat im- group A in comparison to group B mice (P , 0.001).
munoglobulin (Fig. 1). In contrast, the number of CD41 Interstitial fibrosis, assessed semiquantitatively, was sig-
T cells in these treated mice increased to about 50% nificantly less in group A than group B mice. Morpholog-
above that of normal mice at week 6. This result is in ical data are summarized in Table 3.
agreement with that reported by Ghobrial et al [22]. At week 6, although the interstitial volume was sig-
All ADR-treated animals developed renal injury char- nificantly less in group A than that of group B, dense
acterized by proteinuria, FSGS, tubular atrophy, and mononuclear cell infiltrates were found in the intersti-
interstitial damage. Kidneys of mice in group A were tium, consisting of macrophages and CD41 T cells. Al-
hypertrophied, whereas those in group B were pale and most no CD81 cells and rare B cells were found in sec-
atrophic compared with that of normal animals. The tions from group A animals. There was numerically less
kidney weight was significantly higher in group A in macrophage infiltration in group A than in group B (P 5
comparison with other two groups (Table 2). 0.052), but still significantly more in both than in group
Overt proteinuria appeared about five days after the C (P , 0.001). The number of CD41 cells appeared to
ADR administration and remained at a high level increase in group A, in comparison to group B, but this
throughout the study period in both groups A and B, as was not statistically different. IHC staining showed mac-
evaluated by urinalysis. Blood and urine parameters at rophages but no CD41 cells in glomeruli (Fig. 3). IHC
data are also summarized in Table 3.the end of experiment are summarized in Table 2. Uri-
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Table 2. Kidney and body weights, and renal function at 6 weeks
ADR 1 anti-CD8 ADR Negative control
(group A) (group B) (group C)
Kidney weight g 0.560.0a,f 0.360.1 0.460.1
Body weight g 22.764.1 19.363.9 23.265.5
Renal function
Urinary protein mg/24 h 10.463.1e 11.763.9e 1.160.5
Serum albumin g/L 25.065.2 23.864.9 26.662.2
CCr lL/min 71.864.9a,f 29.262.8e 81.963.7
CCr/kidney weight lL/min/g 141.668.7a,b 115.9614.6c 242.7672.0
CCr/body weight lL/min/g 3.260.4a,f 1.560.1e 3.660.7
Values are expressed as means 6 SD. Abbreviation is CCr, creatinine clearance.
a P , 0.05 compared with age-matched negative control (group C)
b P , 0.05 compared with ADR-treated positive control (group B)
c P , 0.01 compared with age-matched negative control (group C)
d P , 0.01 compared with ADR-treated positive control (group B)
e P , 0.001 compared with age-matched negative control (group C)
f P , 0.001 compared with ADR-treated positive control (group B)
DISCUSSION netic cascade, leading to appearance of proteinuria and
that ADR nephropathy was at least partially immune me-The most significant observation to emerge from our
diated. Our previous studies showed that in vivo CD41 cellstudy is that in vivo depletion of CD81 cells by the ad-
depletion aggravated histologic and functional damage inministration of anti-CD8 mAb protected mice from renal
ADR nephropathy, suggesting that CD41 T cells did notfunctional impairment and dramatically reduced struc-
mediate renal injury, but in contrast, had a protectivetural injury, including FSGS, tubular atrophy, and inter-
effect in this model. Moreover, the damaging effect ofstitial expansion in mice with established ADR nephrop-
CD4 depletion was accompanied by an increase in CD81athy. Although the number of inflammatory cells in
cells in the renal interstitium. Lysing of native cells byinterstitium was only mildly reduced in anti-CD8–treated
cytotoxic CD81 T cells appears to be an important causemice in comparison with mice treated with ADR alone,
of organ dysfunction in many situations. Intrinsic kidneythe interstitial volume was significantly less. This is most
cells such as proximal tubular epithelial cells expresslikely due to reduction of tubulointerstitial fibrosis. It
major histocompatibility complex (MHC) class I mole-is also noteworthy that despite marked alleviation of
cules and therefore can be presumably lyzed by CD81histologic and functional damage, proteinuria remained
cells [32]. These considerations prompted us to examinesignificantly elevated in CD8-depleted mice throughout
the effects of CD81 cells depletion in vivo in murinethe experiment. The object of this study was to examine
ADR nephropathy.the effect of CD8 depletion on established ADR ne-
Most CD81 cells have suppressor or cytotoxic func-phropathy, and the persistence of proteinuria permitted
tions. Most CD81 cells are CTLs, but some may be natu-an examination of inflammatory events independent of
ral killer (NK) cells [34, 35]. There are several mecha-proteinuria.
nisms that might explain the role of CD81 CTL in renalFocal segmental glomerulosclerosis is a hallmark of sev-
injury. First, CD81 CTLs are thought to promote renaleral nonimmunological models of renal disease [23–27],
damage through recognition of MHC class I alloantigensamong which ADR-induced nephropathy is considered
and cell-mediated cytotoxicity. CTLs recognize antigento be an excellent analogue of human FSGS [10, 15,
peptides presented on MHC class I and lyze the cells28–31]. Interstitial infiltration with a variety of inflam-
bearing this antigen. Two well-described mechanisms ofmatory cell subtypes is a prominent feature of human and
cell-mediated cytotoxicity have been defined at the mo-experimental FSGS and correlates well with the degree
lecular level, the perforin-dependent pathway, and theof renal insufficiency [32]. However, the role of each
Fas/Fas ligand (FasL) pathway. Both of them can resultinflammatory cell component of interstitial infiltration is
in target cell apoptosis. Second, CD81 T cells producestill poorly understood. In our previous studies, CD41
various cytotoxic cytokines. As NK cells are known tocells, CD81 cells, and macrophages were shown to be
cause target-cell lysis in the MHC-unrestricted reactionsprominent components of interstitial inflammation in
[34, 36], these cells may also be important mediators ofmurine ADR nephropathy [10]. Amore et al suggested
renal injury. Like T cells, NK cells exert cell-mediatedthat the noxious effect of ADR might be decreased by
cytotoxicity, and produce an array of cytokines andT-lymphocyte suppression and even more by the addi-
chemokines.tional inhibition of mononuclear cell function [33]. They
The production of cytokines, such as interferon-ghypothesized that an imbalance of T-lymphocyte subsets,
induced by ADR, might be the first step in the pathoge- (IFN-g), tumor necrosis factor (TNF), and lymphotoxin,
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Fig. 2. Representative sections showing morphological changes as stained by PAS (A–C ) and by Masson’s trichrome (D–F ). Magnification 3400.
(A and D) Saline-treated control mice show normal glomeruli, tubules, and interstitium. (B and E) ADR-treated mice show glomerular sclerosis
and vacuolization (B, arrowhead), tubular collapse and interstitial expansion (B, star), and numerous hyaline and cellular (B, arrow) casts at week
6. In addition, there is obvious interstitial fibrosis (E, arrowheads). (C and F) ADR mice treated with anti-CD8 show mild glomerular sclerosis
and mild tubular dilation and atrophy at week 6, despite hyaline casts indicating proteinuria. However, interstitial cellular infiltration (C, arrowheads)
is widespread, and the fissures between tubules (C, arrows) reveal the edema but not fibrosis in interstitium. There is also less collagen deposition
in the interstitium (F) than that of mice treated with ADR only (E).
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Table 3. Renal morphology and immunohistochemistry at 6 weeks
ADR1anti-CD8 ADR Negative control
(group A) (group B) (group C)
Glomerular changes
GSA lm2 838761758d 570661670c 74506666
GS % 6.561.9e,f 13.062.8e 0
N of nuclei per glomerulus 34.863.7e,f 24.264.9e 45.663.1
Glomerular macrophages cells/10 gcs 1.461.6d 4.862.6e 0.560.7
Tubulointerstitial morphology
Tubular diameter lm 50.3622.9b 93.5647.1c 38.264.7
Tubule cell height lm 9.765.5c,d 3.561.0e 15.964.0
Interstitial volume % 6.362.2e,f 16.463.1e 0.460.1
Interstitial fibrosis (0–41) 1.5 60.5d,e 2.360.8e 0
Interstitial immunohistochemistry cell number/4003 field
CD41 cells 156.0639.1e 148.1619.6e 1.861.5
CD81 cells 0.560.7f 63.369.3e 0.260.5
Macrophages 48.3613.6e 59.8611.4e 8.463.6
B cells 1.762.2 2.661.1 2.163.6
Total 206.4613.9e 273.8610.3e 12.562.3
Values are expressed as means 6 SD. Abbreviations are: GSA, glomerular surface area; GS, glomerulosclerosis; gcs, glomerular cross section.
a P , 0.05 compared with age-matched negative control (group C)
b P , 0.05 compared with ADR-treated positive control (group B)
c P , 0.01 compared with age-matched negative control (group C)
d P , 0.01 compared with ADR-treated positive control (group B)
e P , 0.001 compared with age-matched negative control (group C)
f P , 0.001 compared with ADR-treated positive control (group B)
Fig. 3. Photomicrographs of immunohistochemical (IHC) sections from saline-treated control mice (A), ADR-treated mice (B), and mice treated
with ADR plus anti-CD8 (C ). Sections are stained by antimouse Mac-3 mAb (macrophage). Magnification 3400.
by CD81 cells is consistent with their direct cytotoxic tive glomerulonephritis [41, 42], among other models of
renal disease.function. IFN-g plays a role in macrophage activation
and induction of MHC class I and class II molecules and In the present study, there was a decrease in the num-
ber of macrophages in the glomeruli of mice treatedcan thus contribute to cell-mediated renal injury [37, 38].
In a murine model of anti-TBM disease, Meyers and with ADR plus anti-CD8. This raises the possibility that
macrophages cause damage in ADR nephropathy. Mac-Kelly showed that some of the CD81 effector cells that
cause a delayed-type hypersensitivity (DTH) lesion ex- rophages play a role as antigen-presenting cells. They
can internalize, modify, and present extracellular mole-pressed large amounts of transforming growth factor-b
(TGF-b) [39]. TGF-b is the most potent stimulator of cules as immunogenic fragments in combination with
MHC class I and class II molecules on their cell surfacecollagen, fibronectin, and proteoglycan production in
fibroblasts [40]. Inhibition of TGF-b using antibody or to allow recognition by effector cells. Moreover, macro-
phages synthesize and secrete several cytokines that arenatural neutralizer (decorin) can effectively reduce ex-
tracellular matrix deposition in mesangial prolifera- capable of causing glomerular damage. For example,
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2. Sato T, Oite T, Nagase M, et al: Nephrotoxic serum nephritis ininterleukin-1 and TNF-a can regulate the function of
nude rats: The roles of host immune reactions. Clin Exp Immunol
native glomerular cells, such as mesangial cell prolif- 84:139–144, 1991
3. Alexopoulos E, Seron D, Hartley RB, et al: Lupus nephritis:eration, and may cause alterations in glomerular blood
Correlation of interstitial cells with glomerular function. Kidneyflow and glomerular ultrafiltration [43, 44]. Macrophages
Int 37:100–109, 1990
are also an abundant source of TGF-b, which is likely to 4. Mann R, Zakheim B, Clayman M, et al: Murine interstitial nephri-
tis. IV. Long-term cultured L3T41 T cell lines transfer delayedbe involved in the progression to sclerosis in glomerulo-
expression of disease as I-A-restricted inducers of the effectornephritis [41]. The mitigation of glomerulosclerosis cor-
T cell repertoire. J Immunol 135:286–293, 1985
related well with a reduction of glomerular infiltration 5. Kuroda T, Kawasaki K, Oite T, et al: Nephrotoxic serum nephritis
in nude rats: The role of cell-mediated immunity. Nephron 68:360–with macrophages in the present experiment. Thus, mac-
365, 1994rophages are likely to be important effectors of injury
6. Meyers CM, Tomaszewski JE, Glass JD, et al: The nephritogenic
in this model. T cell response in murine chronic graft-versus-host disease. J Im-
Other plausible explanations of renal injury, apart munol 161:5321–5330, 1998
7. Meyers CM, Kelly CJ: Effector mechanisms in organ-specificfrom the contribution of CD81 cells and macrophages,
autoimmunity. I. Characterization of a CD81 T cell line that medi-should be considered. It is possible that proteinuria per ates murine interstitial nephritis. J Clin Invest 88:408–416, 1991
se could be the cause of renal injury. Although Bertani 8. Penny MJ, Boyd RA, Hall BM: Permanent CD81 T cell depletion
prevents proteinuria in active Heymann nephritis. J Exp Med 188:et al suggested in 1986 that urinary protein itself has
1775–1784, 1998an intrinsic toxicity and could contribute to progressive 9. Kawasaki K, Yaoita E, Yamamoto T, et al: Depletion of CD8
renal disease [45], many researchers have equated this positive cells in nephrotoxic serum nephritis of WKY rats. Kidney
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